Advertisement

Atrial fibrillation burden and heart failure: Data from 39,710 individuals with cardiac implanted electronic devices

Published:January 25, 2021DOI:https://doi.org/10.1016/j.hrthm.2021.01.021

      Background

      Atrial fibrillation (AF) and heart failure (HF) often accompany one another, and each is independently associated with poor outcomes. However, the association between AF burden and outcomes is poorly understood.

      Objective

      The purpose of this study was to describe the association between device-based AF burden and HF clinical outcomes.

      Methods

      We used a nationwide, remote monitoring database of cardiac implantable electronic devices (CIEDs) linked to Medicare claims. We included patients with nonpermanent AF, undergoing new CIED implant, stratified by baseline HF. The outcomes were new-onset HF, HF hospitalization, and all-cause mortality at 1 and 3 years.

      Results

      We identified 39,710 patients who met inclusion criteria (25,054 with HF; 14,656 without HF). Patients with HF were younger (mean age 76.3 vs 78.5 years; P <.001), more often male (65% vs 54%; P <.001), and had higher mean CHA2DS2-VASc scores (5.4 vs 4.1; P <.001). Among those without HF, increasing device-based AF burden was significantly associated with increased risk of new-onset HF (adjusted hazard ratio [HR] 1.09 per 10% AF burden; 95% confidence interval [CI] 1.06–1.12; P <.001) and all-cause mortality (adjusted HR 1.05 per 10% AF burden; 95% CI 1.01–1.10; P = .012). Among patients with HF, increasing AF burden was significantly associated with increased risk of HF hospitalization (adjusted HR 1.05 per 10% AF burden; 95% CI 1.04–1.06; P <.001) and all-cause mortality (adjusted HR 1.06 per 10% AF burden; 95% CI 1.05–1.08; P <.001).

      Conclusion

      Among older patients with AF receiving a CIED, increasing AF burden is significantly associated with increasing risk of adverse HF outcomes and all-cause mortality.

      Graphical abstract

      Keywords

      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to Heart Rhythm
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Wolf P.A.
        • Dawber T.R.
        • Thomas Jr., H.E.
        • Kannel W.B.
        Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study.
        Neurology. 1978; 28: 973-977
        • Deng H.
        • Bai Y.
        • Shantsila A.
        • et al.
        Clinical scores for outcomes of rhythm control or arrhythmia progression in patients with atrial fibrillation: a systematic review.
        Clin Res Cardiol. 2017; 106: 813-823
        • Nieuwlaat R.
        • Prins M.H.
        • Le Heuzey J.Y.
        • et al.
        Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation.
        Eur Heart J. 2008; 29: 1181-1189
        • Steinberg B.A.
        • Piccini J.P.
        When low-risk atrial fibrillation is not so low risk: beast of burden.
        JAMA Cardiol. 2018; 3: 558-560
        • Khazanie P.
        • Liang L.
        • Qualls L.G.
        • et al.
        Outcomes of medicare beneficiaries with heart failure and atrial fibrillation.
        JACC Heart Fail. 2014; 2: 41-48
        • Piccini J.P.
        • Abraham W.T.
        • Dufton C.
        • et al.
        Bucindolol for the maintenance of sinus rhythm in a genotype-defined HF population: the GENETIC-AF Trial.
        JACC Heart Fail. 2019; 7: 586-598
        • Steinberg B.A.
        • Hellkamp A.S.
        • Lokhnygina Y.
        • et al.
        Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial.
        Eur Heart J. 2015; 36: 288-296
        • Van Gelder I.C.
        • Healey J.S.
        • Crijns H.
        • et al.
        Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT.
        Eur Heart J. 2017; 38: 1339-1344
        • Birman-Deych E.
        • Waterman A.D.
        • Yan Y.
        • et al.
        Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors.
        Med Care. 2005; 43: 480-485
        • Quan H.
        • Sundararajan V.
        • Halfon P.
        • et al.
        Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.
        Med Care. 2005; 43: 1130-1139
        • Curtis L.H.
        • Whellan D.J.
        • Hammill B.G.
        • et al.
        Incidence and prevalence of heart failure in elderly persons, 1994-2003.
        Arch Intern Med. 2008; 168: 418-424
        • Piccini J.P.
        • Hammill B.G.
        • Sinner M.F.
        • et al.
        Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke.
        Eur Heart J. 2014; 35: 250-256
        • Roy D.
        • Talajic M.
        • Nattel S.
        • et al.
        Rhythm control versus rate control for atrial fibrillation and heart failure.
        N Engl J Med. 2008; 358: 2667-2677
        • Turagam M.K.
        • Garg J.
        • Whang W.
        • et al.
        Catheter ablation of atrial fibrillation in patients with heart failure: a meta-analysis of randomized controlled trials.
        Ann Intern Med. 2019; 170: 41-50
        • Jones D.G.
        • Haldar S.K.
        • Hussain W.
        • et al.
        A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure.
        J Am Coll Cardiol. 2013; 61: 1894-1903
        • Kirchhof P.
        • Camm A.J.
        • Goette A.
        • et al.
        Early rhythm-control therapy in patients with atrial fibrillation.
        N Engl J Med. 2020; 383: 1305-1316
        • Piccini J.P.
        • Hammill B.G.
        • Sinner M.F.
        • et al.
        Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007.
        Circ Cardiovasc Qual Outcomes. 2012; 5: 85-93
        • Turakhia M.P.
        • Solomon M.D.
        • Jhaveri M.
        • et al.
        Burden, timing, and relationship of cardiovascular hospitalization to mortality among Medicare beneficiaries with newly diagnosed atrial fibrillation.
        Am Heart J. 2013; 166: 573-580